CDSCO Panel Approves Johnson and Johnson's Protocol Amendment proposal for Teclistamab study Dr. Divya Colin2 March 2025 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved Johnson and...
Need More Justification: CDSCO Panel rejects J&J protocol amendment proposal for Teclistamab study Dr. Divya Colin17 March 2024 5:45 PM ISTNew Delhi: Citing that more justification is required, the Subject Expert Committee SEC functional under the Central Drug Standard Control...
CDSCO panel tells JnJ to submit clarification for weight based calculated fixed dose of Teclistamab Isra Zaman23 Aug 2023 12:54 PM ISTBased on the proposal presented by drug major Johnson & Johnson for the protocol amendment of the anticancer drug Teclistamab, the Subject Expert...
Health Bulletin 22/August/2023 Isra Zaman22 Aug 2023 4:24 PM ISTHere are the top health stories for the day:Rural, urban health training center mandatory for starting new medical college: NMC regulationsThe...
Submit Clarification for Weight-based calculated fixed dose: CDSCO panel Tells J&J Over Teclistamab Dr. Divya Colin21 Aug 2023 6:00 PM ISTNew Delhi: Based on the proposal presented by drug major Johnson & Johnson for the protocol amendment of the anticancer drug Teclistamab, the...
European Commission nod to reduced dosing frequency for Janssen Tecvayli Ruchika Sharma20 Aug 2023 11:30 AM ISTTeclistamab is an off-the-shelf (or ready to use) bispecific antibody.
J&J Gets CDSCO Panel Nod To Market Teclistamab sterile liquid in Vials Dr. Divya Colin7 July 2023 6:00 PM ISTNew Delhi: In a significant development, the drug major Johnson and Johnson has got approval from the Subject Expert Committee (SEC) functional under...
CDSCO panel opines Johnson and Johnson to submit details of anticancer drug Teclistamab nod in EU, US Roshni Dhar16 Dec 2022 5:20 PM ISTIn response to the drug major Johnson & Johnson proposal to import and market Teclistamab sterile liquid in vial 30mg/vial and 90mg/vial, the...
Health Bulletin 16/December/2022 Dr. Nandita Mohan16 Dec 2022 4:40 PM ISTHere are the top health news for the day:NMC re-invites applications for establishment of new medical colleges, intake increase of MBBS, PG medical...
CDSCO opines J&J to submit details of Anticancer Drug Teclistamab approval in EU, US Dr. Divya Colin15 Dec 2022 6:00 PM ISTNew Delhi: In response to the drug major Johnson & Johnson proposal to import and market Teclistamab sterile liquid in vial 30mg/vial and...
Janssen Pharma seeks USFDA nod for Teclistamab to treat multiple myeloma Ruchika Sharma30 Dec 2021 11:15 AM ISTRaritan: The Janssen Pharmaceutical Companies of Johnson & Johnson announced the submission of a Biologics License Application (BLA) to the U.S....
Off-the-Shelf Immune Drug Shows Promise in Aggressive Multiple Myeloma Hina Zahid31 Dec 2020 5:30 PM ISTPHILADELPHIA - A subcutaneous injection of the immune-boosting drug teclistamab was found to be safe and elicit responses in a majority of patients...
